Liver X receptor agonists increase airway reactivity in a model of asthma via increasing airway smooth muscle growth

Journal of Immunology

Volumn 181, Issue 6, 2008, Pages 4265-4271

  Birrell, Mark A ^a   De Alba, Jorge ^a   Catley, Matthew C ^a   Hardaker, Elizabeth ^a   Wong, Sissie ^a   Collins, Michael ^a   Clarke, Deborah L ^a   Farrow, Stuart N ^b   Willson, Timothy M ^c   Collins, Jon L ^c   Belvisi, Maria G ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; ANTIGEN; BIOLOGICAL MARKER; BUDESONIDE; EOTAXIN; INTERLEUKIN 1BETA; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MESSENGER RNA; METHACHOLINE; BENZOIC ACID DERIVATIVE; BENZYLAMINE DERIVATIVE; CELL RECEPTOR; DNA BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OVALBUMIN;

AIRWAY; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL PROLIFERATION; CONTROLLED STUDY; EOSINOPHILIA; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOREACTIVITY; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; MUCUS; MUSCLE FIBER CULTURE; MUSCLE GROWTH; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; BROWN NORWAY RAT; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BENZOIC ACIDS; BENZYLAMINES; BRONCHIAL HYPERREACTIVITY; CELL PROLIFERATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MUSCLE, SMOOTH; OVALBUMIN; RATS; RATS, INBRED BN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; UP-REGULATION;

EID: 56149092486     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.6.4265     Document Type: Article

References (31)

1. Repa, J. J., and D. J. Mangelsdorf. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16: 459-481.
2. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383: 728-731.
3. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. USA 96: 266-271.
4. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J.-L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140.
5. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 75: 28240-28245. (Pubitemid 30688949)
6. Repa, J. J., S. D. Turley, J. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529.
7. Schwartz, K., R. M. Lawn, and D. P. Wade. 2000. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274: 794-802. (Pubitemid 30663699)
8. Venkateswaran, A., B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, and P. Tontonoz. 2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc. Natl. Acad. Sci. USA 97: 12097-12102. (Pubitemid 30815144)
9. Joseph, S. B., E. McKilligin, L. Pei, M. A. Watson, A. R. Collins, B. A. Laffitte, M. Chen, G. Noh, J. Goodman, G. N. Hagger, et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99: 7604-7609.
10. Joseph, S. B., A. Castrillo, B. A. Lafitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219. (Pubitemid 36227724)
11. Fowler, A. J., M. Y. Sheu, M. Schmuth, J. Kao, J. W. Fluhr, L. Rhein, J. L. Collins, T. M. Willson, D. J. Mangelsdorf, P. M. Elias, and K. R. Feingold. 2003. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol. 120: 246-255.
12. Liu, S. X., Y. Chen, M. Zhou, and J. Wan. 1998. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages. Atherosclerosis 136: 43-49.
13. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, and C. K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122: 707-721. (Pubitemid 41242636)
14. Englund, M. C., A. L. Karlsson, O. Wiklund, G. Bondjers, and B. G. Ohlsson. 2001. 25-Hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-α secretion in macrophages. Atherosclerosis 158: 61-71.
15. Collins, J. L., A. M. Fivush, M. A. Watson, C. M. Galardi, M. C. Lewis, L. B. Moore, D. J. Parks, J. G. Wilson, T. K. Tippin, J. G. Binz, et al. 2002. Identification of a non-steroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J. Med. Chem. 45: 1963-1966.
16. Ohlsson, B. G., M. C. O. Englund, A. K. Karlsson, E. Knutsen, C. Erixon, H. Skribeck, Y. Liu, G. Bondjers, and O. Wiklund. 1996. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor κB to DNA and the subsequent expression of tumour necrosis factor-α and interleukin- 1β in macrophages. J. Clin. Invest. 98: 78-89.
17. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449. (Pubitemid 36800310)
18. Cao, G., Y. Liang, X. C. Jiang, and P. I. Eacho. 2004. Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect. 17: 35-41. (Pubitemid 38419370)
19. Michael, L. F., J. M. Schkeryantz, and T. P. Burris. 2005. The pharmacology of LXR. Mini Rev. Med. Chem. 5: 729-740.
20. Barnes, P. J. 1996. Pathophysiology of asthma. Br. J. Clin. Pharmacol. 42: 3-10.
21. Underwood, S. L., E. Haddad, M. A. Birrell, K. McCluskie, M. Pecoraro, D. Dabrowski, S. E. Webber, M. L. Foster, and M. G. Belvisi. 2002. Functional characterisation and biomarker identification in the Brown Norway model of allergic airway inflammation. Br. J. Pharmacol. 137: 263-275.
22. Birrell, M. A., K. McCluskie, S. Wong, L. E. Donnelly, P. G. Barnes, and M. G. Belvisi. 2005. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-κB-independent mechanism. FASEB J. 19: 840-841.
23. Birrell, M. A., E. Hardaker, S. Wong, K. McCluskie, M. Catley, J. De Alba, R. Newton, S. Haj-Yahia, K. T. Pun, C. J. Watts, et al. 2005. Iκ-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am. J. Respir. Crit. Care Med. 172: 962-971.
24. Birrell, M. A., C. H. Battram, P. Woodman, K. McCluskie, and M. G. Belvisi. 2003. Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respir. Res. 4: 3.
25. Birrell, M. A., S. Wong, E. Hardaker, M. C. Catley, K. McCluskie, M. Collins, S. Haj-Yahia, and M. G. Belvisi. 2006. IκB kinase-2 independent and dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic. Mol. Pharmacol. 69: 1791-1800.
26. Birrell, M. A., S. Wong, D. J. Hele, K. McCluskie, E. Hardaker, and M. G. Belvisi. 2005. Steroid resistant inflammation in a rat model of COPD is associated with a lack of NF-κB activation. Am. J. Respir. Crit. Care Med. 172: 74-84.
27. Leung, S. Y., P. Eynott, A. Noble, P. Nath, and K. F. Chung. 2004. Resolution of allergic airways inflammation but persistence of airway smooth muscle proliferation after repeated allergen exposures. Clin. Exp. Allergy 34: 213-220.
28. Birrell, M. A., S. Wong, K. McCluskie, E. Hardaker, S. N. Farrow, K. D. Simpson, T. M. Willson, J. L. Collins, and M. G. Belvisi. 2007. Antiinflammatory properties of LXR agonists in human cell based assays and in a rodent model of airway inflammation. Proc. Am. Thorac. Soc. 2: A73.
29. Hirst, S. J., P. J. Barnes, and C. H. Twort. 1992. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am J. Respir. Cell Mol. Biol. 7: 574-581.
30. Delvecchio, C. J., P. Bilan, K. Radford, J. Stephen, B. L. Trigatti, G. Cox, K. Parameswaran, and J. P. Capone. 2007. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Mol. Endocrinol. 21: 1324-1334.
31. Blaschke, F., O. Leppanen, Y. Takata, E. Caglayan, J. Liu, M. C. Fishbein, K. Kappert, K. I. Nakayama, A. R. Collins, E. Fleck, W. A. Hsueh, et al. 2004. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res. 95: 110-123.